MPM Oncology Impact Management LP, 10% Owner at iTeos Therapeutics, Inc. (ITOS), sold 200 shares at $29.99 ($6K) on 2021-04-09, disclosed to the SEC on 2021-04-13.
Scheduled sale ($6k) by 10% Owner under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| HARP | SELL | 2021-04-15 | $1.5M | — | Filing → |
| ITOS | SELL | 2021-04-09 | $2.5M | — | Filing → |
| CGEM | BUY | 2021-01-14 | $6.3M | — | Filing → |